Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2025 (2025-12-31): -597.58%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-436.37%
RETURN ON EQUITY (ROE) AVG 3Y
-156.83%
RETURN ON EQUITY (ROE) AVG 5Y
-114.83%
RETURN ON EQUITY (ROE) AVG 10Y
-36.99%
RETURN ON EQUITY (ROE) AVG 15Y
-26.84%
RETURN ON EQUITY (ROE) AVG 20Y
-38.52%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Dyadic International, Inc.
Market Cap
$16.48M
Return on Equity (ROE)
N/A
TTM Avg
-436.37%
3Y Avg
-156.83%
5Y Avg
-114.83%
Market Cap
$16.75M
Return on Equity (ROE)
-101.76%
TTM Avg
-188.04%
3Y Avg
-167.76%
5Y Avg
-134.95%
Market Cap
$16.76M
Return on Equity (ROE)
-125.30%
TTM Avg
118.50%
3Y Avg
7030.24%
5Y Avg
4638.47%
Market Cap
$16.07M
Return on Equity (ROE)
-271.81%
TTM Avg
-934.34%
3Y Avg
-347.56%
5Y Avg
-265.02%
Market Cap
$16.98M
Return on Equity (ROE)
-34.50%
TTM Avg
-796.82%
3Y Avg
-138.82%
5Y Avg
-407.45%
Market Cap
$17.01M
Return on Equity (ROE)
-71.57%
TTM Avg
-65.12%
3Y Avg
-85.39%
5Y Avg
-90.29%
Market Cap
$17.19M
Return on Equity (ROE)
-54.45%
TTM Avg
-33.23%
3Y Avg
-44.23%
5Y Avg
-52.50%
Market Cap
$15.72M
Return on Equity (ROE)
-348.81%
TTM Avg
-160.92%
3Y Avg
-184.71%
5Y Avg
-151.29%
Market Cap
$15.34M
Return on Equity (ROE)
N/A
TTM Avg
54.00%
3Y Avg
301.36%
5Y Avg
162.15%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyadic International, Inc. (DYAI) | $16.48M | N/A | -436.37% | -156.83% | -114.83% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.75M | -101.76% | -188.04% | -167.76% | -134.95% |
| Palatin Technologies, Inc. (PTN)vs › | $16.76M | -125.30% | 118.50% | 7030.24% | 4638.47% |
| BioCardia, Inc. (BCDA)vs › | $16.07M | -271.81% | -934.34% | -347.56% | -265.02% |
| PAVmed Inc. (PAVM)vs › | $16.98M | -34.50% | -796.82% | -138.82% | -407.45% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | -71.57% | -65.12% | -85.39% | -90.29% |
| Lipocine Inc. (LPCN)vs › | $17.19M | -54.45% | -33.23% | -44.23% | -52.50% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.72M | -348.81% | -160.92% | -184.71% | -151.29% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.34M | N/A | 54.00% | 301.36% | 162.15% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.42M | -951.92% | -161.65% | -122.41% | -87.71% |
ROE
N/A
ROA
-116.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | -597.58% |
| 2025-09-30 | -281.83% |
| 2025-03-31 | -630.91% |
| 2024-12-31 | -235.16% |
| 2024-09-30 | -185.52% |
| 2024-06-30 | -244.33% |
| 2024-03-31 | -173.80% |
| 2023-12-31 | -115.60% |
| 2023-09-30 | -89.78% |
| 2023-06-30 | -78.63% |
| 2023-03-31 | -75.90% |
| 2022-12-31 | -87.80% |
| 2022-09-30 | -93.58% |
| 2022-06-30 | -86.34% |
| 2022-03-31 | -74.82% |
| 2021-12-31 | -71.07% |
| 2021-09-30 | -49.39% |
| 2021-06-30 | -50.09% |
| 2021-03-31 | -40.51% |
| 2020-12-31 | -32.78% |
| 2020-09-30 | -30.35% |
| 2020-06-30 | -25.87% |
| 2020-03-31 | -24.37% |
| 2019-12-31 | -23.16% |
| 2019-09-30 | -19.01% |
| 2019-06-30 | -17.93% |
| 2019-03-31 | -14.35% |
| 2018-12-31 | -13.41% |
| 2018-09-30 | -15.26% |
| 2018-06-30 | -14.09% |
| 2018-03-31 | -13.12% |
| 2017-12-31 | -4.27% |
| 2017-09-30 | -5.46% |
| 2017-06-30 | -4.66% |
| 2017-03-31 | -1.06% |
| 2016-12-31 | -6.26% |
| 2016-09-30 | 99.81% |
| 2016-06-30 | 97.32% |
| 2016-03-31 | 94.25% |
| 2015-12-31 | 89.15% |
| 2014-03-31 | -45.83% |
| 2013-12-31 | -16.67% |
| 2013-09-30 | -44.49% |
| 2013-06-30 | 0.52% |
| 2013-03-31 | 88.05% |
| 2012-12-31 | 75.51% |
| 2006-12-31 | -38.60% |
| 2006-09-30 | -57.49% |
| 2006-06-30 | -53.73% |
| 2006-03-31 | -73.79% |
| 2005-12-31 | -68.85% |
| 2005-09-30 | -79.35% |
| 2005-06-30 | -57.13% |
| 2005-03-31 | -42.81% |
| 2004-12-31 | -24.85% |
